v3.26.1
Cover - USD ($)
 12 Months Ended
Jun. 30, 2026
Aug. 18, 2026
Dec. 31, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Jun. 30, 2026    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2026    
Current Fiscal Year End Date --06-30    
Entity File Number 001-39825    
Entity Registrant Name Intelligent Bio Solutions Inc.    
Entity Central Index Key 0001725430    
Entity Tax Identification Number 82-1512711    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 135 West    
Entity Address, Address Line Two 41st Street    
Entity Address, Address Line Three 5th Floor    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10036    
City Area Code (646)    
Local Phone Number 790-5756    
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol INBS    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 11,712,017
Entity Common Stock, Shares Outstanding   3,027,470  
Documents Incorporated by Reference None    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 1195    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of Intelligent Bio Solutions Inc. (the “Company”) as of June 30, 2026 and 2025, the related consolidated statements of operations and other comprehensive income (loss), changes in shareholders’ equity, and cash flows for each of the two years in the period ended June 30, 2026, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2026 and 2025, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2026, in conformity with accounting principles generally accepted in the United States of America.    
Auditor Name UHY LLP    
Auditor Location Melville, New York